You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 4, April 1979 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE EIGHTY-SIXTH ANNUAL MEETING OF THE WESTERN SURGICAL ASSOCIATION, SCOTTSDALE, ARIZ, NOV 12-15, 1978
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (42)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Altered Coagulation After Albumin Supplements for Treatment of Oligemic Shock

Stemple D. Johnson, MD; Charles E. Lucas, MD; Stanley J. Gerrick, MD; Anna M. Ledgerwood, MD; Roger F. Higgins, PhD

Arch Surg. 1979;114(4):379-383.


Abstract

• Coagulation and need for postoperative blood and plasma therapy were studied in 94 injured patients requiring massive transfusions (average = 14.4); 46 patients, by random selection, received supplemental albumin. Albumin therapy increased total protein concentration (6.4 vs 5.8 g/dL), serum albumin level (4.2 vs 2.9 g/dL), and plasma volume (3,895 vs 3,579 mL) but not RBC volume (1,520 vs 1,530 mL). During the initial five postoperative days, patients receiving albumin required more transfusions (7.1 vs 3.8) and plasma (455 vs 317 mL). This increased need for blood and plasma correlated with a significant decrease in fibrinogen (238 vs 405 mg/dL) and prolongation of the prothrombin time (2.6 vs 1.4 seconds). The partial thromboplastin time was prolonged and the platelet concentration was decreased in albumin-treated patients, but not significantly. Deficiencies in specific coagulation factors have not yet been identified but are being studied. Impaired coagulation is another potential hazard of supplemental albumin therapy, which is probably contraindicated in injured patients.

(Arch Surg 114:379-383, 1979)



Author Affiliations

From the Department of Surgery, Wayne State University, Detroit.


Footnotes

Accepted for publication Dec 12, 1978.

Read before the 86th annual meeting of the Western Surgical Association, Scottsdale, Ariz, Nov 13, 1978.

Reprint requests to Department of Surgery, Wayne State University, Detroit, MI 48201 (Dr Lucas).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Excess mortality after human albumin administration in critically ill patients
Offringa
BMJ 1998;317:223-224.
FULL TEXT  

Human albumin administration in critically ill patients: systematic review of randomised controlled trials • Why albumin may not work
Reviewers and Reviewers
BMJ 1998;317:235-240.
ABSTRACT | FULL TEXT  

Analytic Reviews : Fluid Resuscitation in Head Injury
Shackford
J Intensive Care Med 1990;5:59-68.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.